These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


959 related items for PubMed ID: 25578259

  • 21. Potentials of Mangifera indica in the treatment of depressive-anxiety disorders: possible mechanisms of action.
    Ishola IO, Awodele O, Eluogu CO.
    J Complement Integr Med; 2016 Sep 01; 13(3):275-287. PubMed ID: 27276531
    [Abstract] [Full Text] [Related]

  • 22. Xiaochaihutang attenuates depressive/anxiety-like behaviors of social isolation-reared mice by regulating monoaminergic system, neurogenesis and BDNF expression.
    Ma J, Wang F, Yang J, Dong Y, Su G, Zhang K, Pan X, Ma P, Zhou T, Wu C.
    J Ethnopharmacol; 2017 Aug 17; 208():94-104. PubMed ID: 28687505
    [Abstract] [Full Text] [Related]

  • 23. Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor.
    Chaki S, Hirota S, Funakoshi T, Suzuki Y, Suetake S, Okubo T, Ishii T, Nakazato A, Okuyama S.
    J Pharmacol Exp Ther; 2003 Feb 17; 304(2):818-26. PubMed ID: 12538838
    [Abstract] [Full Text] [Related]

  • 24. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.
    Wesołowska A, Nikiforuk A, Stachowicz K, Tatarczyńska E.
    Neuropharmacology; 2006 Sep 17; 51(3):578-86. PubMed ID: 16828124
    [Abstract] [Full Text] [Related]

  • 25. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
    Consoli D, Leggio GM, Mazzola C, Micale V, Drago F.
    Eur J Pharmacol; 2007 Nov 14; 573(1-3):139-47. PubMed ID: 17669397
    [Abstract] [Full Text] [Related]

  • 26. Xenon produces rapid antidepressant- and anxiolytic-like effects in lipopolysaccharide-induced depression mice model.
    Shao J, Meng L, Yang Z, Yu P, Song L, Gao Y, Gong M, Meng C, Shi H.
    Neuroreport; 2020 Mar 25; 31(5):387-393. PubMed ID: 32106142
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems.
    Wierońska JM, Stachowicz K, Pałucha-Poniewiera A, Acher F, Brański P, Pilc A.
    Neuropharmacology; 2010 Dec 25; 59(7-8):627-34. PubMed ID: 20713068
    [Abstract] [Full Text] [Related]

  • 29. Somatostatin receptor subtype 4 activation is involved in anxiety and depression-like behavior in mouse models.
    Scheich B, Gaszner B, Kormos V, László K, Ádori C, Borbély É, Hajna Z, Tékus V, Bölcskei K, Ábrahám I, Pintér E, Szolcsányi J, Helyes Z.
    Neuropharmacology; 2016 Feb 25; 101():204-15. PubMed ID: 26387439
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Evaluation of the anxiolytic-like profile of the GABAB receptor positive modulator CGP7930 in rodents.
    Jacobson LH, Cryan JF.
    Neuropharmacology; 2008 Apr 25; 54(5):854-62. PubMed ID: 18328507
    [Abstract] [Full Text] [Related]

  • 32. Regulator of G protein signaling 2 differentially regulates nicotine-induced anxiolytic- and antidepressant-like effects in mice.
    Rorabaugh BR, Sprague L, Norman H, Seeley SL, D'Souza MS.
    Eur J Neurosci; 2018 Sep 25; 48(5):2110-2117. PubMed ID: 30103281
    [Abstract] [Full Text] [Related]

  • 33. Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders.
    Leonard SK, Dwyer JM, Sukoff Rizzo SJ, Platt B, Logue SF, Neal SJ, Malberg JE, Beyer CE, Schechter LE, Rosenzweig-Lipson S, Ring RH.
    Psychopharmacology (Berl); 2008 May 25; 197(4):601-11. PubMed ID: 18311561
    [Abstract] [Full Text] [Related]

  • 34. Antidepressant and anxiolytic-like activity of sodium selenite after acute treatment in mice.
    Kędzierska E, Dudka J, Poleszak E, Kotlińska JH.
    Pharmacol Rep; 2017 Apr 25; 69(2):276-280. PubMed ID: 28167456
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Anxiolytic-like effects of alverine citrate in experimental mouse models of anxiety.
    Gupta D, Radhakrishnan M, Kurhe Y.
    Eur J Pharmacol; 2014 Nov 05; 742():94-101. PubMed ID: 25199966
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 48.